See editorial on page 643.

SummaryMist1 plays an important role in organization of the Paneth cell secretory apparatus and managing endoplasmic reticulum stress. This role occurs downstream of Paneth cell lineage allocation and is important for Paneth cell maturation.

Paneth cells, professional secretory cells found within the small intestinal crypt epithelium, are seen as part of the innate immune complex providing antimicrobial secretory products including cryptdins (α-defensins), lysozyme, secretory phospholipase A2, and matrilysin (MMP-7), which influence the enteric microbiome.[@bib1], [@bib2] More recently, Paneth cells have been shown to contribute to the intestinal stem cell (ISC) niche.[@bib3] At the crypt base, Paneth cells are adjacent to and intercalated among ISCs and are therefore in an advantageous position to influence the stem cell microenvironment.[@bib4], [@bib5] In addition to secreting numerous antimicrobial factors, Paneth cells synthesize and secrete factors including epidermal growth factor, granulocyte-macrophage colony-stimulating factor, R-spondin, Wnt3a, tumor growth factor β, and tumor necrosis factor α, which are capable of influencing proliferation and migration of intestinal epithelial cells.[@bib3], [@bib6], [@bib7], [@bib8], [@bib9], [@bib10] Furthermore, we now know that Paneth cells can influence active ISC metabolism.

We recently demonstrated in mice treated with doxorubicin that Paneth cells expand in both granule number and size, and that this is coincident with ISC expansion and epithelial repair. Expansion of the Paneth cell population was also associated with an increase in intermediate cell number.[@bib11] Intermediate cells are Paneth-like cells that are rarely seen in normal adult intestinal epithelium but have been reported in cases of intestinal infection, inflammation, chemotherapy-induced damage, and inhibition of Notch signaling.[@bib12], [@bib13], [@bib14] Although the function of these particular cells is not well-understood, their presence during pathogenic insult suggests that they may play a role in modulating luminal microbiota to prevent further epithelial damage. Alternatively, these cells may reflect a secretory cell progenitor or "transitional cell" present at times of pathologic condition or acceleration of lineage allocation during epithelial repair. Although we know that pathologic insults stimulate the appearance of these cells, the cellular signaling events that encourage the genesis of intermediate cells are not well-understood.

Paneth cells are derived from ATOH1-positive secretory progenitors, and their allocation to this lineage depends on a cadre of transcription factors including SPEDEF, SOX9, and GFI1. Although we have some understanding of the factors necessary for Paneth cell allocation, the factors necessary for Paneth cell maturation (eg, extensive rough endoplasmic reticulum \[RER\], vesicle formation and trafficking) are not as well-understood. MIST1, a basic helix-loop-helix transcription factor found primarily in exocrine secretory cells such as pancreatic acinar cells, zymogenic cells of the stomach, and Paneth cells, regulates downstream genes that control secretory vesicle maintenance and trafficking.[@bib15] Recently, MIST1 has been described as a scaling factor that can be used by specialized secretory cells to regulate secretory capacity.[@bib16] Loss of MIST1 expression in murine gastric epithelium results in decreased granule size, abundance, and electron density and intermediate cell--like features.[@bib17] Together, these data point to potential roles for MIST1 in modulating Paneth cell secretory capacity.

In the current study we hypothesized that MIST1 would play a role in modulating the secretory apparatus in Paneth cells. We show that absence of MIST1 expression in Paneth cells does indeed disrupt components of the secretory pathway. In addition, we demonstrate that absence of MIST1 expression confers an intermediate cell phenotype on Paneth cells. We conclude that MIST1 is necessary for Paneth cell maturation, and that the intermediate cell is consistent with an immature Paneth cell phenotype.

Results {#sec1}
=======

MIST1 protein expression is restricted to Paneth cells at the base of intestinal crypts, as demonstrated by co-localization of MIST1 and lysozyme protein expression, and is contained within the nucleus, which is consistent with it being a transcription factor ([Figure 1](#fig1){ref-type="fig"}*A*). *Mist1*^--/--^ shows no MIST1 protein expression within Paneth cells, and gene expression analysis confirms minimal *Mist1* mRNA expression in knockout mice compared with wild-type ([Figure 1](#fig1){ref-type="fig"}*B*).Figure 1**MIST1 protein is expressed in Paneth cells within the intestinal epithelium.** (*Left*) Immunofluorescence staining of lysozyme (*green*), MIST1 (*red*), and DNA (DAPI) in wild-type (*Mist1*^*+/+*^) and Mist1 knockout (*Mist1*^*--/--*^) mice. *Scale bar* equals 100 μm. (*Right*) Quantitative reverse transcriptase polymerase chain reaction to show relative expression of Mist1 mRNA in wild-type and *Mist1*^*--/--*^ mice. n = 6 mice per group. \*\**P* \<.01.

Studies in pancreas have demonstrated that loss of MIST1 from exocrine cells significantly increases the number of proliferative epithelial cells.[@bib18] To determine whether loss of MIST1 from Paneth cells had a similar impact in small intestinal epithelium, we marked proliferating cells with a 90-minute pulse of the thymidine analogue, 5-iodo-2′-deoxyuridine (IdU). The absence of MIST1 in *Mist1*^--/--^ intestinal epithelial cells did not alter the percentage of IdU^+^ crypt epithelial cells compared with *Mist1*^+/+^ mice ([Figure 2](#fig2){ref-type="fig"}*A* and *B*). In addition, to measure cellular migration we performed a 24-hour pulse with the thymidine analogue, 5-chloro-2′-deoxyuridine (CldU). No difference in cellular migration of intestinal crypt epithelial cells between *Mist1*^--/--^ and *Mist1*^+/+^ mice was observed ([Figure 2](#fig2){ref-type="fig"}*A* and *B*).Figure 2**Loss of MIST1 expression does not affect epithelial proliferation or migration.** (*A*) *Top panel*: IdU was given 90 minutes before death to monitor proliferation by labeling cells in S phase. *Scale bar* equals 100 μm. *Bottom panel*: CldU was given 24 hours before death to evaluate migration of cells. *Scale bar* equals 100 μm. (*B*) Quantification of percentage of IdU^+^ cells per crypt. n = 3 mice per group. (*C*) Quantification of average cell position of highest CldU^+^ cells along the crypt/villus axis. n = 3 mice per group.

We were interested in determining whether lineage allocation in the small intestine is altered in Mist1^KO^ mice at homeostasis. Markers for secretory lineages, including goblet, enteroendocrine, and Paneth cells, were examined and quantified by alcian blue histology and lysozyme immunohistochemistry. In addition, absorptive cells were stained by using sucrase-isomaltase. As seen in [Figure 3](#fig3){ref-type="fig"}*A*, sucrase-isomaltase staining of villus enterocytes from *Mist1*^--/--^ mouse jejunum is similar to that found in wild-type mice. Similarly, we were unable to detect any differences in the number of chromogranin A^+^ cells per crypt or the number of chromogranin A^+^ cells per half villus (images not shown). Lysozyme staining of *Mist1*^--/--^ jejunal tissue revealed positively staining cells located at the crypt base with no indication of ectopic cells along the crypt sides. Overall, there was no difference in the number of lysozyme^+^ cells per crypt between wild-type and *Mist1*^--/--^ mice. Staining with alcian blue, which binds to mucopolysaccharides such as those found in goblet cells, did not demonstrate a difference in the number of positive cells per half villus. However, within the crypt epithelium, there was a significant increase in the total number of alcian blue+ cells per crypt in *Mist1*^--/--^ mice ([Figure 3](#fig3){ref-type="fig"}*A*, *black arrows*). This expansion appears to be due to increased numbers of alcian blue+ Paneth cells at the crypt base. Evaluation of mRNA expression of transcription factors associated with lineage allocation, such as *spdef*, *sox9*, and *gfi3*, revealed no differences between wild-type and *Mist1*^--/--^ mice ([Figure 3](#fig3){ref-type="fig"}*C*). These data suggest that the functions of MIST1 are more specific to optimizing the secretory performance of Paneth cells and not in the allocation of secretory progenitors to the Paneth cell lineage. We recently demonstrated in mice treated with doxorubicin that MIST1 protein was localized to Paneth cell nuclei in the crypt base but was absent in lysozyme-positive cells along the crypt sides. These cells tended to be muc2^+^/lysozyme^+^ intermediate cells.[@bib11] This led us to investigate whether absence of MIST1 expression was associated with the appearance of intermediate cells in crypt epithelium. As seen in [Figure 4](#fig4){ref-type="fig"}*A*, co-staining of jejunal sections for Muc2 and lysozyme demonstrated that lack of MIST1 expression resulted in co-expression of Muc2 and lysozyme in granulated cells at the crypt base. We next used phloxine/tartrizine-alcian blue (PTAB) staining to jejunal tissues to delineate between goblet \[alcian blue^+^ only (PT^--^AB^+^)\], Paneth \[phloxine/tartrizine^+^ only (PT^+^AB^--^)\], and intermediate cells \[both phloxine/tartrizine^+^ and alcian blue^+^ (PT^+^AB^+^)\] cells. Similar to Muc2/lysozyme immunofluorescence, PTAB staining revealed cells that appeared to have a PT^+^AB^+^ (intermediate cell) phenotype ([Figure 4](#fig4){ref-type="fig"}*B*). Quantification of PTAB staining ([Figure 4](#fig4){ref-type="fig"}*C*) revealed a significant decrease in PT^+^AB^--^ (Paneth phenotype) cells and a significant increase in PT^+^AB^+^ (intermediate phenotype) cells in *Mist1*^--/--^ mice compared with wild-type mice. In contrast, no differences were observed in the PT^--^AB^+^ (goblet phenotype) cells between *Mist1*^--/--^ and wild-type mice. This demonstrates that the increased alcian blue staining in the crypt base of *Mist1*^--/--^ mice observed in [Figure 3](#fig3){ref-type="fig"}*B* is directly due to increased numbers of intermediate cells. This finding was corroborated by our Muc2/lysozyme staining showing the presence of Muc2^+^/lysozyme^--^ cells along the crypt sides in both Mist1 null and wild-type mice. These data suggest that a lack of MIST1 expression is necessary for the intermediate cell phenotype, whereas normal mature Paneth cells express MIST1. In addition, intermediate cells derive from cells that have been allocated to the Paneth cell lineage.Figure 3**Loss of *Mist1***^***--/--***^**in small intestine does not alter secretory allocation.** (*A*) Staining for sucrase-isomaltase (enterocytes), alcian blue (goblet cells), and lysozyme (Paneth cells). *Scale bars* equal 100 μm, 50 μm, and 50 μm, respectively. *Black arrows* point out alcian blue^+^ Paneth cells. (*B*) Quantification of chromogranin (Cg) A^+^ cells in crypt and villus compartments. n = 3 mice per group. Quantification of alcian blue^+^ cells in crypt and villus compartments. n = 3 mice per group. \*\**P* \<.01. Quantification of lysozyme^+^ cells per crypt. n = 3 mice per group. (*C*) mRNA expression of transcription factors associated with secretory cell lineage allocation in isolated jejunal crypts from *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice. n = 3--6 mice per group.Figure 4**Mist1 expression prevents Paneth cells from becoming intermediate cells.** (*A*) Immunofluorescence staining of jejunal tissue from *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice for muc2 (*green*) and lysozyme (*red*). Dual positive cells (*yellow*) are intermediate cells. *Scale bar* equals 50 μm. (*B*) Representative PTAB staining of jejunal tissue from *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice. Phloxine tartrizine stains protein-dense areas, Paneth cell--like granules *brown*, and alcian blue stains mucins *blue*. Paneth cell granules from *Mist1*^*+/+*^ Paneth cells stain *brown* (*white arrows*), and granules from *Mist1*^*--/--*^ Paneth cells, which contain mucins, stain *purple*, suggesting an intermediate cell phenotype (*black arrows*). *Scale bar* equals 10 μm. (*C*) Quantification of PTAB staining of jejunal tissue from *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice from (*B*) showing alcian blue^+^ (AB), phloxine/tartrizine^+^ (PT), dual positive (PTAB), and total stained cells (PT + PTAB) per crypt. n = 3 mice per group. \**P* \<.05. \*\**P* \<.01. \*\*\*\**P* \<.0001.

Because Mist1 appears to be associated with the professional secretory identity of Paneth cells, we evaluated the ultrastructure of cellular components crucial for normal secretory capacity via transmission electron microscopy (TEM). Paneth cells from wild-type jejunum contained a well-organized secretory axis consisting of extensive perinuclear RER, supranuclear Golgi apparatus, and electron-dense secretory vesicles ([Figure 5](#fig5){ref-type="fig"}*A*, *inset a*). Examination of Paneth cells from *Mist1*^--/--^ jejunum by TEM revealed several histologic differences, including disorganized, distended RER, misplaced Golgi apparatus, and altered secretory granule morphology ([Figure 5](#fig5){ref-type="fig"}*B* and *b*). This altered morphology was associated with a significant decrease in secretory granule diameter ([Figure 5](#fig5){ref-type="fig"}*C*) in Paneth cells from *Mist1*^--/--^ mice. Others demonstrated that increased intermediate cell numbers can result from inactivation of Notch signaling by epithelium-specific knockout of ADAM10, an enzyme necessary for Notch activation.[@bib19] We wondered whether Notch inactivation was acting through Mist1-regulated pathways. If so, we hypothesized that *Mist1*^--/--^ and *Mist1*^+/+^ mice would exhibit no differences in the numbers of intermediate cells after Notch inactivation, and that the number of intermediate cells would be similar in untreated *Mist1*^--/--^ mice. To evaluate this we treated *Mist1*^--/--^ and wild-type mice with the gamma secretase inhibitor dibenzazepine (DBZ), which broadly disrupts Notch signaling. As can be seen in [Figure 6](#fig6){ref-type="fig"}*A*, treatment with DBZ resulted in the characteristic expansion of secretory lineages, particularly alcian blue^+^ cells, which populate the crypt and villus epithelium. This was observed in both *Mist1*^--/--^ and wild-type mice and was different from *Mist1*^--/--^ mice that were not treated with DBZ. Staining of jejunal tissue from DBZ-treated mice with PTAB ([Figure 6](#fig6){ref-type="fig"}*A* and *B*) confirmed crypts filled with alcian blue--positive goblet cells and revealed that even with inhibition of Notch signaling, a significant decrease in brown staining PT^+^AB^--^ (Paneth cell phenotype) cells and a significant increase in purple staining PT^+^AB^+^ cells (intermediate cell phenotype) in *Mist1*^--/--^ mice compared with wild-type mice are observed. This suggests that Notch signaling is intact in *Mist1*^--/--^, and that MIST1 acts downstream of Notch signaling in Paneth cell--dedicated secretory progenitors.Figure 5**MIST1 expression plays a role in Paneth cell granule size and maturation.** Transmission electron micrographs of crypts from jejunal tissue of (*A*) and (*a*) *Mist1*^*+/+*^ and (*B*) and (*b*) *Mist1*^*--/--*^ mice showing ultrastructural characteristics of Paneth cells. (*C*) Quantification of Paneth cell granule size. n = 3 mice per group. \*\**P* \<.01.Figure 6**Intermediate cell phenotype of *Mist1***^***--/--***^**mice is not due to impaired Notch signaling.** (*A*) *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice were treated with DBZ to inhibit Notch signaling, and jejunal tissues were stained with alcian blue. *Scale bar* equals 125 μm. (*B*) Jejunal tissues from (*A*) were stained with PTAB to evaluate Paneth cells (*yellow arrows*) and intermediate cells (*black arrows*). Paneth cell granules from *Mist1*^*+/+*^ Paneth cells stain *brown*, and granules from *Mist1*^*--/--*^ Paneth cells that contain mucins stain *purple*, suggesting an intermediate cell phenotype. *Scale bar* equals 50 μm. (*C*) Quantification of Paneth cell and intermediate cell numbers. n = 4 mice per group. \*\*\*\**P* \<.0001. \*\**P* \<.01.

Because Paneth cells make up a significant component of the ISC niche, we next evaluated whether the presence of immature Paneth cells in small intestinal crypts of *Mist1*^--/--^ mice affected the number and function of ISCs. First, we evaluated active ISC number by quantification of *Olfm4+* staining after in situ hybridization of jejunal tissue in *Mist1*^--/--^ and *Mist1*^+/+^ mice. As can be seen in in [Figure 7](#fig7){ref-type="fig"}*A*, *Olfm4* in situ hybridization staining appeared visually similar in *Mist1*^--/--^ and *Mist1*^+/+^ mice. Scoring of the staining by using a standardized scoring system (Advanced Cell Diagnostics, Newark, CA) confirmed no difference in active ISC number between *Mist1*^--/--^ and *Mist1*^+/+^ mice ([Figure 7](#fig7){ref-type="fig"}*B*). Others have demonstrated that enteroids can grow in culture in the absence of exogenous Wnt as long as Paneth cells are present.[@bib20] Therefore, we used enteroid culture without added Wnt3 to determine whether the immature Paneth cells from *Mist1*^--/--^ mice were able to sustain enteroid formation and budding. As seen in [Figure 7](#fig7){ref-type="fig"}*C*, crypts from *Mist1*^--/--^ and *Mist1*^+/+^ mice were able to grow and bud in culture. In contrast, crypts from *Ato*^*--/--*^ mice, which are devoid of Paneth cells, did not bud in the absence of Wnt3a and did not survive out to day 6 of culture. Quantification of budding revealed that enteroids from *Mist1*^--/--^ mice accumulated buds at a faster rate than those from wild-type mice ([Figure 7](#fig7){ref-type="fig"}*D*). As early as day 3 of culture we counted significantly fewer spheroids in *Mist1*^--/--^ cultures compared with *Mist1*^+/+^, that is, more enteroids from *Mist1*^--/--^ cultures were budding. This difference continued to day 6 in culture where the number of enteroids from *Mist1*^--/--^ crypts with 4 or more buds was significantly greater than enteroids from *Mist1*^+/+^ mice.Figure 7**Loss of MIST1 expression improves active ISC function in culture.** (*A*) Representative in situ hybridization of *Olfm4* in jejunal tissue from *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice. *Scale bar* equals 20 μm. (*B*) Quantification of *Olfm4* in situ hybridization staining using ACD scoring system. NS, not significant. (*C*) Micrographs of enteroid cultures derived from jejunal crypts from *Mist1*^*+/+*^, *Mist1*^*--/--*^ and *Atoh1*^*--/--*^ mice 1, 3, and 6 days after culture. (*D*) Quantification of budding percentage of *Mist1*^*+/+*^, *Mist1*^*--/--*^ and *Atoh1*^*--/--*^ enteroids over time. n = 5 *Mist1*^*+/+*^ and *Mist1*^*--/--*^ mice were used for 4 independent culture experiments. n = 2 *Atoh1*^*--/--*^ mice for 2 independent culture experiments to verify the inability of *Atoh*^*--/--*^ crypts to grow in minimal culture medium. For each experiment n = 6 separate wells from each mouse were used for quantifying budding. \*\**P* \<.01. \*\*\**P* \<.001.

Discussion {#sec2}
==========

MIST1 has been shown to serve as a maturation and scaling factor in exocrine cells from other organs such as pancreas and stomach; however, its function in small intestinal Paneth cells is still unclear. In this study, we demonstrated that lack of MIST1 expression in Paneth cells resulted in an intermediate cell phenotype characterized by smaller, immature secretory granules, disorganized secretory apparatus, and co-expression of both goblet and Paneth cell markers. Furthermore, we demonstrated that the absence of MIST1 did not impact overall secretory lineage allocation and was independent of Notch signaling. Finally, we showed that although loss of MIST1 expression did not alter overall proliferative numbers or active ISC numbers in the small intestinal crypt in vivo, it did increase the budding capacity of enteroids in vitro. MIST1 plays a significant role in maturation of exocrine cells in various organ systems, including the small intestine in this study, and alteration of its expression is associated with changes in cellular proliferation, morphology, and localization.[@bib17], [@bib21] For example, ectopic expression of Mist1 in pancreatic cell lines inhibits proliferation by induction of p21^CIP1/WAF1^.[@bib18] Conversely, knockdown of MIST1 in this cell line decreased p21^CIP1/WAF1^ and increased proliferation.[@bib18] Furthermore, absence of MIST1 in pancreatic acini results in mislocalization of secretory granules, and in the cells of the gastric glands, its absence results in decreased granule size and nuclear positioning within the cell.[@bib21], [@bib22] Our current studies suggest that unlike what has been shown in the pancreas, the absence of Mist1 in small intestinal Paneth cells does not alter overall proliferation or cellular migration in crypt epithelium. In addition, nuclear location was not altered in Paneth cells of *Mist1*^--/--^ mice, but we did observe decreased secretory granule size and alterations in RER ultrastructure. Our data suggest that although Paneth cells are similar to other exocrine cells in many ways, MIST1 in the Paneth cell may play less of a role in cellular polarity but is still important for secretory machinery.

Notch signaling plays a significant role in controlling the cell fate decisions of intestinal epithelial progenitor cells into absorptive and secretory lineages. Inhibition of this pathway, by either chemical inhibition of γ-secretase (eg, DBZ) or knockout of associated genes such as *Adam10*, *Dll1*, *Dll4*, or *Rbp-j*, relegates cells to the secretory phenotype, particularly alcian blue--positive cells.[@bib19], [@bib23], [@bib24], [@bib25] Tsai et al[@bib19] demonstrated that the loss of ADAM10 in intestinal epithelium also increased the number of intermediate cells. Our observation that loss of MIST1 expression directed Paneth cells to an intermediate cell phenotype led us to question whether Notch signaling was disrupted in those cells. Treatment of wild-type and *Mist1*^--/--^ mice with DBZ led us to 2 conclusions: (1) that loss of MIST1 does not disrupt Notch signaling and (2) that MIST1 functions downstream of Paneth cell lineage allocation.

Our current understanding of allocation of cells to the Paneth cell lineage in the small intestine includes accumulation of ATOH1 in progenitors that are negative for Notch signaling, along with expression of the transcription factors GFI1, SOX9, and SPDEF.[@bib26], [@bib27], [@bib28], [@bib29] Loss of any one of these transcription factors alters or ablates Paneth cell numbers. Although rare in homeostasis, intermediate cells have been described in the small intestinal crypt in response to a number of damaging and pathogenic stimuli, including doxorubicin and helminth infections, with very little clarity of their source.[@bib11], [@bib30] Our data suggest that MIST1, working downstream of the above mentioned transcription factors, plays a role in preventing the intermediate cell phenotype, which is an immature Paneth cell phenotype on the basis of our observations. We presume that expression of MIST1 is dependent on one or more of those same transcription factors and subsequently drives the Paneth cell to its fully mature, secretory form. However, associations between MIST1 and Paneth cell--related transcription factors have not been demonstrated in the literature with the exception of overexpression of MIST1 in hepatoblasts leading to decreased expression of SOX9.[@bib31] Further studies of the association of MIST1 with other Paneth cell--related transcription factors are warranted to determine whether MIST1 is truly part of the Paneth cell lineage allocation process.

Alternatively, the intermediate cell phenotype we observe in *Mist1*^--/--^ Paneth cells could be due to an inability of these cells to appropriately handle ER stress. Others have demonstrated that MIST1 expression is downstream of expression of the ER stress--associated transcription factor XBP1 and that MIST1 can inhibit XPB1 expression.[@bib32], [@bib33] Targeted deletion of XBP1 in intestinal epithelium results in apoptosis and loss of Paneth cells.[@bib34], [@bib35] Presumably this is due to an inappropriate response to ER stress; however, a similar result is observed when ATOH1 (a transcription factor necessary for Paneth cell lineage allocation) is deleted from intestinal epithelium.[@bib26] Our TEM data showing disorganized RER and secretory granules suggest a disruption in normal ER response. However, our studies used a transgenic knock-in of LacZ or Cre recombinase (Cre) into the MIST1 allele to create whole animal loss of Mist1 expression. Therefore, it is difficult for us to delineate whether the alterations we see in Paneth cell phenotype are due to a role of MIST1 in lineage allocation or in promoting normal ER stress response. Additional studies using *Mist1* floxed mice with an epithelial-specific or Paneth cell--specific, inducible Cre driver would allow the deletion of MIST1 in otherwise mature Paneth cells and provide greater insight into the role of MIST1 in Paneth cell lineage allocation and/or ER stress response. When cultured in minimal culture medium containing no exogenous Wnt, we observed increased budding of crypts from *Mist1*^--/--^ mice compared with crypts from *Mist1*^+/+^ mice, suggesting increased activity of active ISCs in culture and/or increased secretion of trophic factors from Paneth cells. Our in situ hybridization for *Olfm4* mRNA expression suggests that the increased budding is not due to an increase in the number of active ISCs in isolated crypts. Because Paneth cells play a substantial role in influencing the ISC niche by secreting trophic factors such as Wnt3a or sPLA2, one possibility is that *Mist1*^--/--^ Paneth cells have an altered secretome that becomes evident once put into culture.[@bib3], [@bib36] Alternatively, as has been demonstrated in the pancreas, loss of MIST1 expression in Paneth cells could impact expression of gap junctional proteins such as connexins 26 and 32, which can serve as tumor suppressors.[@bib37], [@bib38] Loss of these junctional proteins is permissive to tumor formation in a variety of organs including breast, colon, lung, and liver. Thus, once placed in a pro-proliferative environment such as culture medium, the *Mist1*^--/--^ crypts lack normal factors that would suppress excessive proliferation and budding.

The findings of this study demonstrate that Mist1 plays a significant role in maturation of Paneth cells in the small intestine, particularly within the context of their secretory mechanics. Our data also implicate MIST1 in maturation of Paneth cells and preventing an intermediate cell phenotype, warranting further study of the role MIST1 plays in Paneth cell--specific gene expression.

Methods {#sec3}
=======

Animals {#sec3.1}
-------

Female mice aged 10--16 weeks were used for this study. Experimental procedures were approved by the Institutional Animal Care and Use Committee of NC State University. A select cohort of mice were given intraperitoneal injection (1 mg each) of CldU 24 hours and intraperitoneal injection of IdU 90 minutes before killing. In all cases after death, the small intestine was flushed with ice-cold phosphate-buffered saline (PBS) (pH 7.4), and a piece of middle jejunum was fixed in 10% buffered formalin and embedded in paraffin as previously reported.[@bib11] *Mist1*^*nLacZ*^ mice, which are null for *Mist1*, were used as *Mist1*^--/--^ and were acquired from the laboratory of Dr Jason Mills (Washington University) with permission from Dr Stephen Konieczny (Purdue University). *Atoh*^*fl/fl*^ mice were acquired from Jackson Laboratory (Bar Harbor, ME) and crossed with *Vil*^*CreERT2*^ mice obtained from Dr Larry Chen with permission of Dr Sylvie Robine.

Dibenzazepine Treatment {#sec3.2}
-----------------------

Mice were injected intraperitoneally with 30 μmol/kg DBZ once per day for 5 days before death and tissue collection on day 6 as previously described.[@bib39] Briefly, 25 mg DBZ was dissolved in 180 μL dimethyl sulfoxide to make a 0.3 mol/L stock solution. For injection, DBZ stock solution was diluted as follows (for 2 mL of injection solution); 400 μL 0.5% Tween-80 was added to 600 μL and gently vortexed. Next, 20 μL of 0.3 mol/L DBZ stock and 1 mL of 1% methylcellulose were added, and the suspension was vigorously passed through an 18-gauge needle to break up precipitated DBZ. Jejunal tissue was rinsed, fixed in 10% buffered formalin, and embedded in paraffin. Sections were cut and stained with alcian blue or with PTAB.

Histology {#sec3.3}
---------

Formalin-fixed paraffin embedded specimens were oriented to provide cross sections perpendicular to the long axis of the bowel, and 5-μm sections were used for evaluating general morphology. Longitudinal sections of crypts or villi were selected for scoring on the basis that a single, continuous layer of epithelium followed from crypt base to villus base and from the crypt-villus junction to the villus tip, respectively. For all quantitative analyses, 30 crypts or villi per animal (n = 3--6 animals) were randomly selected and scored. Crypts or villi were only scored if they had a single layer of continuous epithelium and were well-oriented. Tissue was stained with H&E, the goblet cell marker alcian blue, or PTAB. PTAB staining allows the differentiation of Paneth cells from intermediate cells by staining protein-dense Paneth cells brown and mucin-rich intermediate cells purple. H&E stained sections from n = 3 mice per time point were used to calculate granule diameter in Paneth cells. Proliferative index was calculated by dividing the number of IdU-positive cells per crypt by the total number of cells per crypt. Migration was calculated by determining the highest cell position starting at the crypt base that exhibited immunohistochemical staining for CldU. A minimum of 60 granules were measured, with an average of 88 granules measured per section. Granules were measured under oil emersion at ×160 magnification by using AxioVision software (Carl Zeiss Microscopy, Jena, Germany), which allowed the measurement of granule diameter. PTAB-stained sections were used for scoring of PT^+^AB^--^ (Paneth cells), PT^--^AB^+^ (goblet cells), and PT^+^AB^+^ (intermediate cells) cell numbers. Scoring of all parameters was done in a blinded fashion by using Axio Imager software on images captured using an Axio Imager A1 microscope and an AxioCam MRC 5 high resolution camera (Carl Zeiss Microimaging, Inc, Thornwood, NY).

Immunohistochemistry and Immunofluorescence {#sec3.4}
-------------------------------------------

For immunohistochemistry, slides were deparaffinized, rehydrated, and incubated in 3% hydrogen peroxide for 15 minutes at room temperature (RT) to quench endogenous peroxidase activity. Sections were treated to heat-induced epitope retrieval by using Thermo Scientific Lab Vision heat-induced epitope retrieval buffer L according to manufacturer's instructions (cat. \#TA-135-HBL; Thermo Fisher Scientific, Waltham, MA). Next, slides were blocked in 10% normal goat serum in Tris buffer for 1 hour at RT. For slides stained with anti-IdU antibody, blocking was instead performed with the Thermo Fisher Scientific Rodent Block (cat. \#TA-060-QRB) for 30 minutes at RT according to manufacturer's instructions. Primary antibodies were diluted in Thermo Diluent (cat. \#TA-125-ADQ; Thermo Fisher Scientific) and applied to each section: CldU (cat. \#NB500-169; Novus Biologicals, Centennial, CO) at 1:200 dilution; lysozyme (cat. \#NCL-MURAM; Leica Novocastra, Wetzlar, Germany) at 1:250 dilution; chromogranin A (cat. \#ab15160; Abcam, Cambridge, United Kingdom) at 1:400 dilution incubated overnight at 4°C; and IdU (cat. \#347580; BD Biosciences, Franklin Lakes, NJ) at 1:200 dilution for 2 hours at RT. Sections were then washed and incubated with biotinylated secondary antibodies for 60 minutes at RT, with the exception of slides stained with anti-IdU antibody, which were incubated with the mouse on mouse horseradish-peroxidase polymer for 15 minutes at RT (cat. \#TL-060-QPHM; Thermo Fisher Scientific). After washing, slides were incubated in Vectastain ABC reagent (cat. \#PK-7200; Vector Laboratories, Burlingame, CA) for 30 minutes and then developed in a DAB substrate solution. For immunofluorescence, slides were deparaffinized, rehydrated, and then subjected to antigen retrieval in 10 mmol/L sodium citrate buffer (pH 6.0) with 0.05% Tween 20 for 30 minutes at 100°C. After blocking in 5% bovine serum albumin in PBS for 1 hour at RT, primary antibodies were diluted in 1% bovine serum albumin in PBS and applied as follows: Mist1 (1:200, cat. \#sc-80984; Santa Cruz Biotechnology, Santa Cruz, CA) sucrase-isomaltase (1:100, cat. \#sc-27603; Santa Cruz Biotechnology); muc2 (1:100, cat. \#sc-15334; Santa Cruz Biotechnology); and lysozyme (1:100, cat. \#sc-27958; Santa Cruz Biotechnology) for 1 hour at RT. Slides were washed and then incubated with fluorescently labeled secondary antibodies. After washing, Vectashield with DAPI antifade mounting media was applied, and slides were coverslipped and sealed with clear nail polish.

Transmission Electron Microscopy {#sec3.5}
--------------------------------

TEM was used to verify Paneth cell phenotype. For TEM, jejunal tissue pieces were fixed overnight in fixative (2% paraformaldehyde, 2.5% glutaraldehyde, 0.15 mol/L sodium phosphate, pH 7.4), washed in sodium phosphate buffer, post-fixed for 1 hour in potassium ferrocyanide--reduced osmium, and embedded in PolyBed 812 epoxy resin (cat. \#08791-500; Polysciences, Warrington, PA). Cross sections (1 μm) were cut, stained with 1% toluidine blue, and examined by light microscopy to isolate the area of interest. Ultrathin sections were cut (70- to 80-nm thickness), mounted on 200 mesh copper grids, and stained with 4% aqueous uranyl acetate for 15 minutes, followed by Reynolds' lead citrate for 8 minutes. The sections were observed by using a LEO EM-910 transmission electron microscope (LEO Electron Microscopy, Inc, Thornwood, NY), accelerating voltage of 80 kV, and digital images were taken with Gatan Orius SC 1000 CCD Camera (Gatan, Inc, Pleasanton, CA).

Crypt Isolation {#sec3.6}
---------------

Jejuna were flushed with ice-cold PBS, cut open along the long axis of the tissue, and cut into 1- to 2-cm pieces. Pieces were washed in 5 mL ice-cold PBS, placed in 5 mL ice-cold 5 mmol/L EDTA/1XPBS pH 7.4, and shaken at 4°C for 30 minutes. Next, pieces were gently shaken for 15 seconds. Pieces were moved to a fresh tube containing 5 mL ice-cold PBS and shaken for 1--2 minutes until crypts detach from tissue. We added 5 mL 2% sorbitol in 1× PBS, inverted to mix the samples, and filtered the crypts through a 70-μm filter. Filtered crypts were spun down at 200*g* for 5 minutes at 4°C. Supernatant was aspirated off, and pellet was used for RNA isolation or enteroid culture.

Crypt Culture {#sec3.7}
-------------

For enteroid culture, approximately 40 freshly isolated jejunal crypts were suspended in 10 μL of growth factor reduced Matrigel (cat. \#356231; Corning, Corning, NY) per well of a 24- well plate by using methods similar to those previously published by Sato et al.[@bib3] After 30 minutes at 37°C to solidify the Matrigel, 200 μL of Wnt3a-free culture medium \[DMEM/F12 Advanced media (cat. \#12634-010; Thermo Fisher Scientific), 1× penicillin/streptomycin (cat. \#15140-122; Thermo Fisher Scientific), 1× HEPES (cat. \#15630-106; Thermo Fisher Scientific), 1× Glutamax (cat. \# 35050-079; Thermo Fisher Scientific), 1× N2 (cat. \# 17502-048; Thermo Fisher Scientific), 1× B27 (cat. \#17504-044; Thermo Fisher Scientific), 50 ng/mL EGF (cat. \#2028-EG; R&D Systems, Minneapolis, MN), 100 ng/mL Noggin (cat. \#250-38; Peprotech, Rocky Hill, NJ), and 500 ng/mL R-spondin (cat. \#4645-RS/CF; R&D Systems)\] was added to each well. Media were changed every other day. For quantification of budding, enteroids were evaluated on days 1, 3, and 6 after plating for number of buds. Enteroids with no buds were defined as spheres. The remaining enteroids were grouped into categories of 1, 2, 3, or 4+ buds. Data are presented as percentage.

Gene Expression Analysis {#sec3.8}
------------------------

Total RNA was isolated from jejunal crypts by using Trizol reagent (Life Technologies, Carlsbad, CA) according to the manufacturer's directions. Lack of contamination with genomic DNA was verified by running 1 μg of total RNA on a 0.9% agarose gel. Using the TaqMan One-Step RT-PCR Master Mix (cat. \#4309169; Applied Biosystems, Inc, Foster City, CA) and Taqman Gene Expression assays for Mtgr1 (Mm01251302_m1), Spdef (Mm00600221_m1), Atoh1 (Mm00476035_s1), Gfi1 (Mm00515853_m1), Sox9 (Mm00448840_m1), and β-actin (Mm00607939_s1), 100 ng of total RNA was subjected to real time reverse transcriptase polymerase chain reaction. Relative changes in expression levels were calculated by the ΔΔCt method using the Mist1^WT^ total RNA as the baseline.

In Situ Hybridization {#sec3.9}
---------------------

Using the RNAscope 2.5 Chromogenic Assay protocol outlined by the manufacturer (cat. \#322300; Advanced Cell Diagnostics, Newark, CA), in situ hybridization of *Olfm4* was performed on formalin-fixed, paraffin-embedded jejunal tissue with some modifications. Briefly, paraffin sections were baked at 60°C overnight and then deparaffinized. Sections were incubated in hydrogen peroxide for 10 minutes at RT and subjected to antigen retrieval for 15 minutes in boiling target retrieval solution. Sections were then incubated in protease solution for 30 minutes at 40°C and then subjected to hybridization using the antisense probe for *Olfm4*. Slides were then blindly scored using the ACD scoring system on the basis of the amount of hybridization/cell.

Statistics {#sec3.10}
----------

All quantitative results are presented as means ± standard deviation. All paired data were subjected to two-tailed *t* tests. Budding data were analyzed by two-way analysis of variance using genotype and bud number as the independent variables and using Bonferroni's multiple comparisons test. Counts of PTAB cells were analyzed by two-way analysis of variance using genotype and cell type as the independent variables and using Bonferroni's multiple comparisons test. For all comparisons, *P* value \<.05 was considered significant.
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